{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T12:28:42Z","timestamp":1780489722641,"version":"3.54.1"},"reference-count":15,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,30]],"date-time":"2024-12-30T00:00:00Z","timestamp":1735516800000},"content-version":"vor","delay-in-days":2800,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["intpsychogeriatrics.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Psychogeriatrics"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1017\/s1041610216002441","type":"journal-article","created":{"date-parts":[[2017,1,26]],"date-time":"2017-01-26T10:07:04Z","timestamp":1485425224000},"page":"859-862","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["Buspirone for the treatment of dementia with behavioral disturbance"],"prefix":"10.1016","volume":"29","author":[{"given":"Maria R.","family":"Santa Cruz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priscilla C.","family":"Hidalgo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meredith S.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cornelius W.","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzanne","family":"Holroyd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1017\/S1041610216002441_bb0010","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1097\/00019442-199622430-00011","article-title":"Buspirone vs. haloperidol: a double-blind trial for agitation in a nursing home population with Alzheimer's disease","volume":"4","author":"Cantillon","year":"1996","journal-title":"American Journal of Geriatric Psychiatry"},{"key":"10.1017\/S1041610216002441_bb0015","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.jpsychires.2008.02.003","article-title":"Agitated behavior in persons with dementia: the relationship between type of behavior, its frequency, and its disruptiveness","volume":"43","author":"Cohen-Mansfield","year":"2008","journal-title":"Journal of Psychiatric Research"},{"key":"10.1017\/S1041610216002441_bb0020","first-page":"1169","article-title":"Buspirone in treatment of agitated demented patient","volume":"1","author":"Colenda III","year":"1998","journal-title":"Lancet"},{"key":"10.1017\/S1041610216002441_bb0025","first-page":"6","article-title":"Buspirone for anxiety and agitation in dementia","volume":"28","author":"Cooper","year":"2003","journal-title":"Journal of Psychiatry and Neuroscience"},{"key":"10.1017\/S1041610216002441_bb0030","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1007\/s11920-012-0288-5","article-title":"Behavioral disturbance in dementia","volume":"14","author":"Desai","year":"2012","journal-title":"Current Psychiatry Reports"},{"key":"10.1017\/S1041610216002441_bb0035","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1056\/NEJMoa1114058","article-title":"Relapse risk after discontinuation of risperidone in Alzheimer's disease","volume":"367","author":"Devanand","year":"2012","journal-title":"New England Journal of Medicine"},{"key":"10.1017\/S1041610216002441_bb0040","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1001\/jama.2014.93","article-title":"Effect of citalopram on agitation in Alzheimer disease: the CitAD randomized clinical trial","volume":"311","author":"Porsteinsson","year":"2014","journal-title":"Journal of the American Medical Association"},{"key":"10.1017\/S1041610216002441_bb0045","doi-asserted-by":"crossref","first-page":"350","DOI":"10.3122\/jabfm.2012.03.100183","article-title":"Guidelines for the management of cognitive and behavioral problems with dementia","volume":"25","author":"Sadowsky","year":"2012","journal-title":"Journal of the American Board of Family Medicine"},{"key":"10.1017\/S1041610216002441_bb0050","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1111\/j.1532-5415.1990.tb02407.x","article-title":"A metaanalysis of controlled trials of neuroleptic treatment in dementia","volume":"38","author":"Schneider","year":"1990","journal-title":"Journal of the American Geriatrics Society"},{"key":"10.1017\/S1041610216002441_bb0055","first-page":"CD008191","article-title":"Antidepressants for agitation and psychosis in dementia","volume":"2","author":"Seitz","year":"2011","journal-title":"Cochrane Database Systematic Review"},{"key":"10.1017\/S1041610216002441_bb0060","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1177\/106002809202601114","article-title":"Non-neuroleptic treatment of disruptive behavior in organic mental syndromes","volume":"26","author":"Smith","year":"1992","journal-title":"The Annals of Pharmacotherapy"},{"key":"10.1017\/S1041610216002441_bb0065","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1017\/S1041610201007578","article-title":"Agitation in demented patients in an acute care hospital: prevalence, disruptiveness, and staff burden","volume":"13","author":"Sourial","year":"2001","journal-title":"International Psychogeriatrics"},{"key":"10.1017\/S1041610216002441_bb0070","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1002\/yd.2330247610","article-title":"Treatment of agitation in dementia","volume":"76","author":"Tariot","year":"1997","journal-title":"New Directions for Mental Health Services"},{"key":"10.1017\/S1041610216002441_bb0075","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1016\/j.jagp.2015.05.006","article-title":"Time to response in citalopram treatment for agitation in Alzheimer disease","volume":"11","author":"Weintraub","year":"2015","journal-title":"American Journal of Geriatric Psychiatry"},{"key":"10.1017\/S1041610216002441_bb0080","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.kjms.2011.10.025","article-title":"Mood stabilizers for the treatment of behavioral and psychological symptoms of dementia: an update review","volume":"28","author":"Yeh","year":"2012","journal-title":"Kaohsiung Journal of Medical Sciences"}],"container-title":["International Psychogeriatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1041610224010263?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1041610224010263?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/S1041610216002441","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,8]],"date-time":"2025-01-08T09:32:18Z","timestamp":1736328738000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1041610224010263"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5]]},"references-count":15,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017,5]]}},"alternative-id":["S1041610224010263"],"URL":"https:\/\/doi.org\/10.1017\/s1041610216002441","relation":{},"ISSN":["1041-6102"],"issn-type":[{"value":"1041-6102","type":"print"}],"subject":[],"published":{"date-parts":[[2017,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Buspirone for the treatment of dementia with behavioral disturbance","name":"articletitle","label":"Article Title"},{"value":"International Psychogeriatrics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1017\/S1041610216002441","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2017 International Psychogeriatric Association. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}